Product Wiki · Recalls · Health Canada Consumer Product Safety

Certain nut butters, peanuts, sugar and tahini from Vicrossano Inc — recall 49426

Health Canada Consumer Product Safety · Canada · 2013-03-23 · Class 2

As described by Health Canada Consumer Product Safety: Certain nut butters, peanuts, sugar and tahini from Vicrossano Inc. may contain Salmonella or other harmful bacteria

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
Health Canada Consumer Product Safety
Recall identifier
49426
Date of alert
2013-03-23
Country / jurisdiction
Canada
Risk level
Class 2
Risk type
recall
Product category
Food
Product type
Consumer product safety
Notice status
Archived by the issuing authority — kept for reference
Reported risk: Ottawa, March 23, 2013 - The Canadian Food Inspection Agency (CFIA) is warning the public not to consume and retailers, restaurants and institutions not to sell or use the nut butters, peanuts, sugar or tahini described below because the products may be contaminated with Salmonella or other harmful bacteria. These products have been distributed in Alberta, Ontario, Quebec New Brunswick, Nova Scotia, Prince Edward Island and may have been distributed in other provinces as well. Consumers who cannot determine the original product identity are advised to check with their retailer to determine if they have one of the affected products. There have been no reported illnesses associated with the consumption of these products.
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/certain-nut-butters-peanuts-su

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.